HETEROGENEITY IN ACTION: THE ROLE OFPASSIVEPERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH-Reference-Cited by-同舟云学术

HETEROGENEITY IN ACTION: THE ROLE OFPASSIVEPERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH

Published:2013-10-09 Issue:3 Volume:23 Page:359-373
ISSN:1057-9230
Container-title:Health Economics
language:en
Short-container-title:Health Econ.

Author:

Basu Anirban¹,Jena Anupam B.²,Goldman Dana P.³,Philipson Tomas J.⁴,Dubois Robert⁵

Affiliation:

1. Department of Health Services; University of Washington, Seattle and the National Bureau of Economic Research, Cambridge MA; Seattle WA USA

2. Department of Health Care Policy; Harvard Medical School; Boston MA USA

3. Leonard D. Schaeffer Center for Health Policy and Economics; University of Southern California; California USA

4. Irving B. Harris School of Public Policy Studies; University of Chicago; Chicago USA

5. National Pharmaceutical Council; Washington D.C. USA

Publisher

Wiley

Subject

Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hec.2996/fullpdf

Reference34 articles.

1. Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care;Basu;Journal of Health Economics,2011a

2. Estimating decision-relevant comparative effects using instrumental variables;Basu;Statistics in Biosciences,2011b

3. Person-centered treatment (PeT) effects using instrumental variables. National bureau of economic research working paper No w18056;Basu;Journal of Applied Econometrics,2013

4. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models;Basu;Biostatistics,2005

5. Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients;Basu;Health Economics,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating Policies of Expanding Versus Restricting First-Line Treatment Choices: A Cost-Effectiveness Analysis Framework;Value in Health;2024-04

2. Understanding differences between what alternate propensity score methods estimate;Journal of Managed Care & Specialty Pharmacy;2023-04

3. Incentivizing Prescription Drug Switching to Reduce Patient and Health Plan Spending: A Microsimulation Model;Value in Health;2021-10

4. Estimation and inference for policy relevant treatment effects;Journal of Econometrics;2021-06

5. Competition Effects of Charter Schools: New Evidence from North Carolina;Journal of School Choice;2020-07-03